Sinovac Biotech Ltd.
http://www.sinovac.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Sinovac Biotech Ltd.
Divergent Progress For Chinese Developers Of COVID Antivirals, Vaccines
Some of China's makers of COVID-19 antivirals are fast-tracking neutralizing antibodies and peptide fusion inhibitors in clinical trials, while vaccine developers are embroiled in a tougher situation against the mutating coronavirus.
COVID-19 Windfalls Carry Pharma Into Stormy Times: Key Takeaways From Scrip 100 And Outlook 2023
The past couple of years have generated important growth for the pharma industry thanks to its drugs and vaccines for COVID-19. But with the IRA, high inflation, rising interest rates and chilly public markets, biopharma faces challenges this year. Here, we summarize key messages from In Vivo’s Outlook 2023.
Pfizer Leads An Unusual Year For The Scrip 100
Pfizer catapulted back into the lead in the pharmaceutical rankings on the strength of COVID-19 revenues while BioNTech and Moderna both made the list for the first time.
Pandemic Drives China Surge In Asia 100 Sales
Notable new entrants moved into the Asia 100 this year, with growth catalyzed by COVID-19 vaccines.
Company Information
- Industry
- In Vitro Diagnostics
-
Pharmaceuticals
- Drug Delivery
- Vaccines
-
Medical Devices
- Implantable Devices
- Monitoring Equipment & Devices
-
Biotechnology
- Gene Therapy, Cell Therapy
- Large Molecule
- Other Names / Subsidiaries
-
- Beijing Kexing Bioproducts
- Sinovac Dalian Vaccine Technology Co., Ltd.
- Sinovac (Cayman) Limited
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice